H. Lundbeck, Synaptic Pharmaceutical’s stockholders approve merger agreement with H. Lundbeck A/S

Synaptic Pharmaceutical Corporation announced today that, at a special meeting of stockholders held earlier today, its stockholders approved the merger of Synaptic and a subsidiary of H. Lundbeck A/S ("Lundbeck").